Stay updated on BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed; no substantive content changes detected.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of facility names and locations in various countries, as well as a revision update to version 3.0.0. Notably, several medical terms related to proteins and antibodies have been added, while previous entries regarding antineoplastic agents and immune checkpoint inhibitors have been removed.SummaryDifference3%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page.